To seek capital appreciation through investment in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.
Find out MoreDate | Source | Headline | |
---|---|---|---|
3rd May 2024 | 5:42 pm | PRN | Transaction in Own Shares |
3rd May 2024 | 3:19 pm | PRN | Net Asset Value(s) |
3rd May 2024 | 7:00 am | PRN | Compliance with Market Abuse Regulation |
2nd May 2024 | 2:25 pm | PRN | Net Asset Value(s) |
1st May 2024 | 2:22 pm | PRN | Net Asset Value(s) |
1st May 2024 | 10:17 am | PRN | Total Voting Rights |
30th Apr 2024 | 3:09 pm | PRN | Net Asset Value(s) |
29th Apr 2024 | 1:20 pm | PRN | Net Asset Value(s) |
26th Apr 2024 | 3:29 pm | PRN | Net Asset Value(s) |
25th Apr 2024 | 2:34 pm | PRN | Net Asset Value(s) |
24th Apr 2024 | 3:11 pm | PRN | Net Asset Value(s) |
23rd Apr 2024 | 2:21 pm | PRN | Net Asset Value(s) |
22nd Apr 2024 | 2:04 pm | PRN | Net Asset Value(s) |
19th Apr 2024 | 5:34 pm | PRN | Transaction in Own Shares |
19th Apr 2024 | 2:31 pm | PRN | Net Asset Value(s) |
18th Apr 2024 | 2:22 pm | PRN | Net Asset Value(s) |
17th Apr 2024 | 2:11 pm | PRN | Net Asset Value(s) |
16th Apr 2024 | 2:44 pm | PRN | Net Asset Value(s) |
15th Apr 2024 | 2:59 pm | PRN | Net Asset Value(s) |
15th Apr 2024 | 10:24 am | PRN | Monthly Fact Sheet as at 31 March 2024 |
12th Apr 2024 | 2:46 pm | PRN | Net Asset Value(s) |
11th Apr 2024 | 2:52 pm | PRN | Net Asset Value(s) |
10th Apr 2024 | 3:28 pm | PRN | Net Asset Value(s) |
9th Apr 2024 | 3:12 pm | PRN | Net Asset Value(s) |
8th Apr 2024 | 1:51 pm | PRN | Net Asset Value(s) |
5th Apr 2024 | 2:35 pm | PRN | Net Asset Value(s) |
4th Apr 2024 | 2:07 pm | PRN | Net Asset Value(s) |
3rd Apr 2024 | 2:07 pm | PRN | Net Asset Value(s) |
2nd Apr 2024 | 5:05 pm | PRN | Net Asset Value(s) |
2nd Apr 2024 | 10:30 am | PRN | Total Voting Rights |
28th Mar 2024 | 5:20 pm | PRN | Transaction in Own Shares |
28th Mar 2024 | 2:30 pm | PRN | Net Asset Value(s) |
27th Mar 2024 | 3:03 pm | PRN | Net Asset Value(s) |
26th Mar 2024 | 3:40 pm | PRN | Net Asset Value(s) |
25th Mar 2024 | 2:49 pm | PRN | Net Asset Value(s) |
22nd Mar 2024 | 5:30 pm | PRN | Transaction in Own Shares |
22nd Mar 2024 | 2:37 pm | PRN | Net Asset Value(s) |
21st Mar 2024 | 2:25 pm | PRN | Net Asset Value(s) |
20th Mar 2024 | 2:41 pm | PRN | Net Asset Value(s) |
20th Mar 2024 | 9:10 am | EQS | Edison issues update on The Biotech Growth Trust (BIOG): Onwards and upwards for performance recovery |
19th Mar 2024 | 2:37 pm | PRN | Net Asset Value(s) |
18th Mar 2024 | 1:28 pm | PRN | Net Asset Value(s) |
15th Mar 2024 | 5:25 pm | PRN | Transaction in Own Shares |
15th Mar 2024 | 2:39 pm | PRN | Net Asset Value(s) |
14th Mar 2024 | 2:02 pm | PRN | Net Asset Value(s) |
14th Mar 2024 | 12:10 pm | PRN | Director/PDMR Shareholding |
14th Mar 2024 | 9:40 am | PRN | Monthly Fact Sheet as at 29 February 2024 |
13th Mar 2024 | 2:08 pm | PRN | Net Asset Value(s) |
13th Mar 2024 | 12:57 pm | PRN | Director Declaration |
12th Mar 2024 | 4:39 pm | PRN | Director/PDMR Shareholding |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.